Table 1: Baseline characteristics.
|
GLP-1 use prior to surgery (N = 50) |
Control Group (N = 50) |
Age (years) |
44.2 ± 14.0 |
45.8 ± 11.0 |
Gender |
84% female |
86% female |
Ethnicity |
74% White |
78% White |
|
22% Black |
16% Black |
|
4% Hispanic |
6% Hispanic |
Height (in) |
65.5 ± 3.5 |
66.0 ± 3.0 |
Consult weight (lbs) |
314.8 ± 47.8 |
286.9 ± 48.6 |
Consult BMI (kg/m2) |
51.6 ± 6.7 |
46.1 ± 5.9 |
Consult EBW (lbs) |
162.0 ± 41.2 |
131.6 ± 40.8 |
Surgery weight (lbs) |
288.8 ± 42.8 |
275.5 ± 44.2 |
Surgery BMI (kg/m2) |
47.3 ± 5.3 |
44.3 ± 5.3 |
Surgery EBW (lbs) |
136.0 ± 35.1 |
120.2 ± 36.4 |
Weight loss before surgery (lbs) |
26.0 ± 21.9 |
11.4 ± 33.3 |
Medical history |
T2DM 42% |
T2DM 22% |
|
Pre-DM 30% |
Pre-DM 38% |
|
HTN 52% |
HTN 34% |
A1C |
6.3 ± 1.3% |
5.7 ± 0.7% |